Industry news
Veniti Inc.is acquired by Boston Scientific and with it the Vici venous stent system
Boston Scientific Corporation announced it has signed an agreement to acquire Veniti, Inc., a privately-held company in Fremont, California which has developed and commercialized the Vici Venous Stent system for treating venous obstructive disease. The self-expanding, nitinol Vici stent system was developed specifically for use in the venous anatomy, which presents different challenges than placing stents in the arterial vascular system. The Vici stent is designed to withstand compression and maintain patency and flexibility over the course of a patient's life expectancy.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins